Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

GSK and Genmab’s Arzerra fails lymphoma trial

Cancer drug unable to beat Roche's MabThera in late-stage study

- PMLiVE

Boehringer launches ASCO blog to talk about lung cancer

Not Just One Disease set to cover a range of topics, including the patient journey

Novartis day

Novartis licenses Ophthotech eye drug in $1bn deal

Fovista is a potential first-in-class treatment for wet AMD

China flag thumb

Sanjing Pharma chief leaps to his death amid corruption probe

Liu Zhanbin was chairman and chief executive of the Harbin Pharmaceutical Group subsidiary

EU flag

EU approval for J&J’s hepatitis C drug

Olysio can be used in combination with Gilead’s Sovaldi

- PMLiVE

Medicus International rebrands as Discovery London

Med comms agency is also promoted to European hub for Publicis' Discovery network

Pharma deals during April 2014

Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month

Deal Watch table for April 2014

Table listing all the major pharma mergers, acquisitions and collaborations in the past month

- PMLiVE

Havas Worldwide appoints healthcare head in SE Asia

Victor Joseph ‘VJ’ Yamat is managing director of healthcare operations in emerging region

- PMLiVE

Theories abound after Publicis/Omnicom merger breaks down

Firms end talks to become world’s largest advertising agency

- PMLiVE

Unions blast ‘negative consequences’ for Sweden of a Pfizer-AZ deal

Say proposed takeover posed an imminent risk to country's life science sector

- PMLiVE

Eisai resubmits Fycompa to G-BA for pricing assessment

But German distribution of epilepsy drug remains on hold until reimbursement settled

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links